Andrew J Muir Selected Research

Andrew J Muir Research Topics

Disease

44	Infections 12/2021 - 05/2004
31	Chronic Hepatitis C 12/2021 - 03/2002
30	Fibrosis (Cirrhosis) 01/2023 - 03/2002
16	Liver Diseases (Liver Disease) 01/2023 - 05/2012
16	Hepatitis C 01/2021 - 07/2003
11	Anemia 12/2015 - 02/2005
9	End Stage Liver Disease 11/2022 - 10/2002
7	Sclerosing Cholangitis 12/2022 - 05/2003
7	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2019
7	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2017
7	Virus Diseases (Viral Diseases) 04/2015 - 03/2002
5	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 02/2008
5	Exanthema (Rash) 12/2011 - 08/2008
4	Portal Hypertension 01/2022 - 08/2008
4	Hemolytic Anemia 02/2012 - 10/2010
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 05/2016
3	Acute Liver Failure (Fulminant Hepatic Failure) 11/2022 - 08/2010
3	Body Weight (Weight, Body) 04/2010 - 04/2009
2	Hemorrhage 09/2022 - 08/2008
2	Disease Progression 12/2021 - 12/2019
2	Hepatitis 12/2021 - 09/2015
2	Hepatic Encephalopathy 09/2021 - 01/2021
2	Neoplasms (Cancer) 06/2021 - 01/2016
2	Cholangiocarcinoma 06/2021 - 05/2003
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 10/2018 - 09/2018
2	Autoimmune Hepatitis 10/2018 - 10/2006
2	Pruritus (Itching) 09/2018 - 08/2008
2	HIV Infections (HIV Infection) 01/2018 - 08/2010
2	Hepatitis B 01/2017 - 08/2010
2	Substance-Related Disorders (Drug Abuse) 05/2016 - 03/2002
2	Coinfection 11/2015 - 08/2010
1	Reperfusion Injury 01/2023
1	Cholestasis 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Reinfection 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2021
1	Glycogen Storage Disease Type III (Cori's Disease) 12/2021
1	Muscle Weakness 12/2021
1	Hepatomegaly 12/2021
1	Glycogen Storage Disease IIIB 12/2021
1	Malnutrition (Nutritional Deficiencies) 11/2020

Drug/Important Bio-Agent (IBA)

37	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 07/2003
22	Antiviral Agents (Antivirals)IBA 12/2021 - 08/2008
15	InterferonsIBA 01/2017 - 02/2005
12	telaprevirIBA 04/2015 - 08/2008
8	Protease Inhibitors (Protease Inhibitor)IBA 01/2017 - 04/2009
7	Interferon-alpha (Interferon Alfa)IBA 01/2015 - 05/2004
6	RNA (Ribonucleic Acid)IBA 01/2021 - 02/2009
6	SofosbuvirIBA 12/2015 - 04/2014
6	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 02/2015 - 01/2012
6	peginterferon alfa-2a (Pegasys)FDA Link 04/2014 - 08/2008
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2018
5	CollagenIBA 01/2022 - 10/2018
5	sofosbuvir drug combination ledipasvirIBA 12/2021 - 05/2014
5	NucleotidesIBA 09/2015 - 05/2014
4	simtuzumabIBA 01/2022 - 10/2018
4	Alkaline PhosphataseIBA 01/2021 - 01/2019
4	ledipasvirIBA 09/2015 - 04/2014
3	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2023 - 09/2018
3	Bile Acids and Salts (Bile Acids)IBA 01/2023 - 01/2019
3	EnzymesIBA 12/2021 - 08/2010
3	glecaprevir and pibrentasvirIBA 10/2020 - 01/2017
3	daclatasvirIBA 01/2016 - 05/2015
3	Inosine TriphosphataseIBA 02/2012 - 10/2010
3	peginterferon alfa-2b (Pegintron)FDA Link 02/2011 - 05/2004
3	Interferon LambdaIBA 09/2010 - 06/2010
2	Proton Pump InhibitorsIBA 09/2021 - 01/2021
2	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2019 - 10/2018
2	aldaferminIBA 01/2019 - 09/2018
2	AlbuminsIBA 08/2015 - 02/2015
2	asunaprevirIBA 05/2015 - 05/2015
2	8- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA 05/2015 - 05/2015
2	CreatinineIBA 02/2015 - 07/2011
2	CholesterolIBA 07/2012 - 06/2010
2	LDL CholesterolIBA 12/2011 - 06/2010
2	albinterferon alfa-2bIBA 10/2010 - 02/2009
1	cilofexorIBA 01/2023
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2023
1	SodiumIBA 11/2022
1	selonsertibIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2021
1	GlycogenIBA 12/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2021
1	CarbohydratesIBA 06/2021
1	AntigensIBA 06/2021
1	Fetal Proteins (Fetoprotein)IBA 06/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	insulin receptor-related receptor (IRR)IBA 01/2021

Therapy/Procedure

36	Therapeutics 01/2022 - 03/2002
19	Liver Transplantation 01/2023 - 10/2002
5	Drug Tapering 04/2014 - 10/2010
4	Surgical Portasystemic Shunt (Portosystemic Shunt) 09/2022 - 11/2020
4	Transjugular Intrahepatic Portasystemic Shunt 01/2022 - 11/2020
4	Transplantation 11/2020 - 05/2012
2	Subcutaneous Injections 01/2019 - 10/2018
2	Complementary Therapies (Alternative Medicine) 07/2017 - 05/2010
1	Perioperative Period 01/2023
1	Diet Therapy (Therapy, Diet) 12/2021
1	Aftercare (After-Treatment) 01/2021
1	Length of Stay 11/2020